In subgroup analyses stratified by hepatic steatosis, participants without steatosis exhibited higher serum ANGPTL4 concentrations in the IGT (p < 0.001) and NDD (p = 0.001) groups compared with NGT; similar associations were observed among participants with hepatic steatosis (both p < 0.001 for IGT and NDD compared with NGT). This evidence concerns the gene ANGPTL4 and fatty liver disease.